For in vitro diagnostic use. Others LPA2 IVD LPA2 CPS_000163 Tina-quant Lipoprotein (a) Gen.2 08 106 126 190 8 106 126 190 08106126190 8106126190 08106126190 LPA2, 150T, cobas c pack green LPA2 07613336140833 Reagents, kits 150 tests cobas c 303/503/703 true 05 852 633 190 5 852 633 190 05852633190 5852633190 05852633190 LPA Gen.2, 200Tests cobas c 701 LPA2 04015630930586 Reagents, kits 200 tests cobas c 701/702 true 05 852 625 190 5 852 625 190 05852625190 5852625190 05852625190 LPa Gen.2, 150Tests cobas c/INT LPA2 04015630929962 Reagents, kits 150 tests COBAS INTEGRA 400 Plus, cobas c 311/501/502 true 08106126500 LPA2 Tina-quant Lipoprotein (a) Gen.2 en 6 FF00000007101A0E FF000000051EF60E 08106126190 10299 cobas c 703 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of lipoprotein (a) in human serum and plasma on cobas c systems. en 0208106126190c503 LPA2 Tina-quant Lipoprotein (a) Gen.2 en 3 FF00000006A1880E FF00000004CEA00E 08106126190 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of lipoprotein (a) in human serum and plasma on cobas c systems. The measurement of Lp(a) is useful in evaluating lipid metabolism disorders and assessing atherosclerotic cardiovascular disease in specific populations, when used in conjunction with clinical evaluation and other lipoprotein tests. en 05852633500 LPA2 Tina-quant Lipoprotein (a) Gen.2 en 6 FF0000000669300E FF0000000004AD0E 05852633190 2492 cobas c 702 310 cobas c 701 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of lipoprotein (a) in human serum and plasma on cobas c systems. en 0205852633190c701 LPA2 Tina-quant Lipoprotein (a) Gen.2 en 3 FF00000006A18C0E FF000000002BE20E 05852633190 2492 cobas c 702 310 cobas c 701 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of lipoprotein (a) in human serum and plasma on cobas c systems. The measurement of Lp(a) is useful in evaluating lipid metabolism disorders and assessing atherosclerotic cardiovascular disease in specific populations, when used in conjunction with clinical evaluation and other lipoprotein tests. en 0205852625190c501 LPA2 Tina-quant Lipoprotein (a) Gen.2 en 3 FF00000006A18B0E FF000000002BE30E 05852625190 308 cobas c 311 2324 cobas c 502 309 cobas c 501 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of lipoprotein (a) in human serum and plasma on cobas c systems. The measurement of Lp(a) is useful in evaluating lipid metabolism disorders and assessing atherosclerotic cardiovascular disease in specific populations, when used in conjunction with clinical evaluation and other lipoprotein tests. en 0205852625190COIN LPA2 Tina-quant Lipoprotein (a) Gen.2 en 3 FF00000006A18D0E FF00000000292D0E 05852625190 302 COBAS INTEGRA 400 plus Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of lipoprotein (a) in human serum and plasma on COBAS INTEGRA systems. The measurement of Lp(a) is useful in evaluating lipid metabolism disorders and assessing atherosclerotic cardiovascular disease in specific populations, when used in conjunction with clinical evaluation and other lipoprotein tests. en 0105852625190COIN LPA2 Tina-quant Lipoprotein (a) Gen.2 en 6 FF00000004894F0E FF000000000E420E 05852625190 302 COBAS INTEGRA 400 plus Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of lipoprotein (a) in human serum and plasma on COBAS INTEGRA systems. en 05852625500 LPA2 Tina-quant Lipoprotein (a) Gen.2 en 7 FF0000000667D60E FF000000000B160E 05852625190 308 cobas c 311 2324 cobas c 502 309 cobas c 501 302 COBAS INTEGRA 400 plus Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of lipoprotein (a) in human serum and plasma on cobas c and COBAS INTEGRA systems. en

User Profile

Select your user profile

LPA2

Overview

Detailed Specifications

Ordering Information

Compatible Instruments

Technical Documents

Access important product documentation including relevant certificates and other resources.